Ecovyst Inc. filed its third-quarter 2026 earnings disclosure on November 5, 2026, reporting a 51% year-over-year increase in sales and raising its full-year Adjusted EBITDA guidance for continuing operations through the period ended September 30, 2026.
Key Highlights
- Sales of $308.6 million in Q3 2026, up $103.7 million or 51% from $204.9 million in Q3 2025, according to the filing.
- Net income of $18.4 million, compared to $0.2 million in the year-ago quarter, with diluted net income per share of $0.17.
- Adjusted EBITDA of $61.2 million, an increase of $3.7 million or 6% versus $57.5 million in Q3 2025.
- Full-year Adjusted EBITDA guidance raised to a range of $208 million to $212 million, up from the prior range of $195 million to $207 million.
- Calabrian acquisition closed June 30, 2026, with Q3 2026 representing the first full quarter of ownership; integration described as "underway" by the CEO.
- 263,719 shares repurchased in Q3 2026 at an average price of $10.25 per share, for a total cost of $2.7 million.
- Total available liquidity of $167.0 million as of September 30, 2026, comprising $71.2 million in cash and $95.8 million in ABL facility availability.
Ecovyst Reports Q3 2026 Results Driven by Sulfuric Acid Volumes and Calabrian Contribution
Ecovyst Inc. (NYSE:ECVT), described in the filing as "a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives," reported third-quarter 2026 results from continuing operations that reflected both organic volume growth and the first full quarter of its Calabrian business acquisition. The company disclosed that the increase in sales was attributable to higher sales volume, favorable pricing, and the Calabrian contribution, with average selling prices rising primarily due to a pass-through of higher sulfur costs of approximately $67 million and favorable contractual pricing for regenerated sulfuric acid.
According to the filing, Adjusted EBITDA of $61.2 million was above what CEO Kurt J. Bitting described as "the high end of our guidance range." The filing noted that the Adjusted EBITDA increase was "primarily driven by higher sales volume and favorable net pricing, partially offset by higher manufacturing costs, general inflation and higher transportation costs." The company also disclosed that on December 31, 2025, it completed the sale of its Advanced Materials and Catalysts business, and that segment's results are reported as discontinued operations for all periods presented.
On the balance sheet, the filing reported total gross debt of $497.1 million and a Net Debt Leverage Ratio of 2.1x as of September 30, 2026, up from 1.2x at December 31, 2025. The filing attributed this increase to the $100 million term loan increase associated with the Calabrian acquisition, partially offset by only one quarter of Calabrian-related Adjusted EBITDA in the trailing twelve-month period. For the nine months ended September 30, 2026, cash flow from operating activities for continuing operations was $80.7 million, compared to $77.0 million for the same period in 2025. The company also raised its full-year sales outlook to $1,050 million to $1,070 million and its Adjusted Free Cash Flow guidance to $50 million to $60 million.
What Was Disclosed
Ecovyst disclosed Q3 2026 financial results for continuing operations, including a 51% sales increase, raised full-year 2026 guidance across multiple metrics, details on the Calabrian acquisition integration, liquidity and debt levels as of September 30, 2026, and stock repurchase activity during the quarter.




Please wait processing your request...